exc-20240430Pennsylvania10 South Dearborn StreetP.O. Box 805379ChicagoIllinois60680-5379(800)483-3220☐0001109357False00011093572024-04-302024-04-30
| | | | | | | | | | | |
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| FORM | 8-K | |
| | | |
| CURRENT REPORT | |
| Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| April 30, 2024 | |
| Date of Report (Date of earliest event reported) | |
| | | | | | | | | | | | | | |
Commission File Number | | Name of Registrant; State or Other Jurisdiction of Incorporation; Address of Principal Executive Offices; and Telephone Number | | IRS Employer Identification Number |
| | | | |
001-16169 | | EXELON CORPORATION | | 23-2990190 |
| | (a Pennsylvania corporation) 10 South Dearborn Street P.O. Box 805379 Chicago, Illinois 60680-5379 (800) 483-3220 | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | | | | | | | | | | | | |
Securities registered pursuant to Section 12(b) of the Act: |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
EXELON CORPORATION: | | | | |
Common Stock, without par value | | EXC | | The Nasdaq Stock Market LLC |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | |
Indicate by check mark whether any of the registrants are emerging growth companies as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ |
| | |
If an emerging growth company, indicate by check mark if any of the registrants have elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Shareholders ("Annual Meeting") of Exelon Corporation ("Exelon" or the "Company") was held on April 30, 2024. Shareholders of record as of March 1, 2024, were entitled to receive notice and vote at the Annual Meeting.
The following tables present the votes cast with respect to each item of business properly presented at the meeting.
1.Each of the nominees for election to the Board of Directors were elected based on the following votes:
| | | | | | | | | | | | | | | | | |
DIRECTOR | FOR | %FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
Paul Bowers | 794,504,143 | 98.41% | 12,817,845 | 1,330,880 | 75,846,299 |
Calvin G. Butler, Jr. | 803,622,858 | 99.57% | 3,435,698 | 1,594,312 | 75,846,299 |
Marjorie Rodgers Cheshire | 798,911,179 | 98.97% | 8,285,273 | 1,456,416 | 75,846,299 |
Linda Jojo | 799,857,583 | 99.08% | 7,420,755 | 1,374,530 | 75,846,299 |
Charisse Lillie | 802,554,461 | 99.41% | 4,685,807 | 1,412,600 | 75,846,299 |
Anna Richo | 803,445,704 | 99.55% | 3,613,893 | 1,593,271 | 75,846,299 |
Matthew Rogers | 804,154,216 | 99.60% | 3,182,169 | 1,316,483 | 75,846,299 |
Bryan Segedi | 804,201,563 | 99.63% | 2,967,168 | 1,484,137 | 75,846,299 |
John Young | 761,139,046 | 94.28% | 46,119,108 | 1,394,714 | 75,846,299 |
2.The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for 2024 was approved based upon the following votes:
| | | | | | | | | | | | | | |
FOR | %FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
828,314,197 | 93.76% | 55,045,868 | 1,139,102 | N/A |
3.The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved based upon the following votes:
| | | | | | | | | | | | | | |
FOR | %FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
744,873,039 | 93.68% | 50,200,009 | 13,579,820 | 75,846,299 |
4.The proposal to approve an amendment to Exelon's Articles of Incorporation to allow shareholders owning at least 25% of Exelon's stock to call a special meeting was approved based upon the following votes:
| | | | | | | | | | | | | | |
FOR | %FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
798,867,295 | 99.03% | 7,818,789 | 1,966,784 | 75,846,299 |
5.The shareholder proposal to adopt a shareholder right to call a special shareholder meeting was not approved based upon the following votes:
| | | | | | | | | | | | | | |
FOR | %FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
272,694,031 | 33.97% | 529,901,740 | 6,057,097 | 75,846,299 |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. | | | | | | | | |
Exhibit No. | | Description |
| | |
101 | | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
104 | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| EXELON CORPORATION |
| |
| /s/ Gayle Littleton |
| Gayle Littleton |
| Executive Vice President, Chief Legal Officer, and Corporate Secretary |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
May 3, 2024
EXHIBIT INDEX
| | | | | | | | |
Exhibit No. | | Description |
| | |
101 | | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
104 | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |